GENE WAVE

Serial Number 87732655
606

Registration Progress

Application Filed
Dec 22, 2017
Under Examination
Nov 20, 2018
Approved for Publication
Sep 25, 2018
Published for Opposition
Sep 25, 2018
Registered

Trademark Image

GENE WAVE

Basic Information

Serial Number
87732655
Filing Date
December 22, 2017
Published for Opposition
September 25, 2018
Abandonment Date
December 27, 2021
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 27, 2021
Classes
005

Rights Holder

Generation Bio Co.

03
Address
301 Binney Street, Suite 401
Cambridge, MA 02142

Ownership History

Generation Bio Co.

Original Applicant
03
Cambridge, MA

Generation Bio Co.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
John V. Hobgood, Esquire

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

46 events
Date Code Type Description Documents
Dec 27, 2021 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Dec 27, 2021 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
May 22, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 21, 2021 EX5G S SOU EXTENSION 5 GRANTED Loading...
May 21, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 13, 2021 EXT5 S SOU EXTENSION 5 FILED Loading...
May 13, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 2, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Feb 2, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Feb 2, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 2, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 2, 2021 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Feb 2, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Nov 17, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 13, 2020 EX4G S SOU EXTENSION 4 GRANTED Loading...
Nov 13, 2020 EXT4 S SOU EXTENSION 4 FILED Loading...
Nov 13, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 22, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 20, 2020 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 20, 2020 EXT3 S SOU EXTENSION 3 FILED Loading...
May 20, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 21, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 19, 2019 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 19, 2019 EXT2 S SOU EXTENSION 2 FILED Loading...
Nov 19, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 24, 2019 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jul 24, 2019 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
May 14, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 11, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 11, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
May 11, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 20, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 25, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 25, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 5, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 23, 2018 ALIE A ASSIGNED TO LIE Loading...
Aug 13, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 8, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 7, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 7, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 1, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 1, 2018 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 1, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 21, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 10, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 26, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of genetic disorders and diseases; genetic medicines for the treatment of genetic diseases, related diseases having a genetic cause or component and disease states resulting from gene expression or genetic sequence

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"GENE"